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Background
Community engagement is vital to sustaining long-term
commitment to the search for an effective HIV vaccine.
Due to this central role, the HIV Vaccine Trials Network
(HVTN) has begun an initiative to better evaluate the
diverse engagement occurring across its sites. The purpose
of this presentation will be to describe the process used to
develop our evaluation methods and to explore the eval-
uation design given the broader scope and mission of
community engagement around HIV vaccine research.
Methods
In 2008 the HVTN formed a working group to lead the
implementation of an evaluation system for its commu-
nity engagement program. They examined the program,
developed a program theory and logic model, designed
initial measures, investigated software options, and made
plans for a pilot.
Results
We will present the logic model and metrics and describe
a pilot program to test the model. Examination of the
community engagement program identified two broad
program components: community outreach and commu-
nity partnerships. We will examine these two program
components and present metrics that are based on our
program theory. These metrics are both process indicators
(new and ongoing activities, event attendance, and con-
tact with community partners) and outcome indicators
(knowledge among stakeholders, evidence of strength-
ened relationships with stakeholders, and stakeholder sat-
isfaction with partnerships and community outreach).
Conclusion
This presentation will provide insight into an initiative to
evaluate community engagement. We will discuss details
of the processes, from cultivation of the dedicated work-
ing group to implementation of the pilot instrument. We
will focus on the program logic model, explaining details
of the program theory including how the outcome indica-
tors will be operationalized into evaluable metrics. The
intent of the logic model is one of generalizability across
a large, multi-site, global network; organizations in
attendance may find that its evolution and design reso-
nate with their own community education goals.
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